Markets:

Overview

News

Currencies

International

Treasuries

Medipharm Labs Corp (TSX:LABS)

0.0850 +0.0050 (+6.25%)

Streaming Delayed Price Updated: 9:44 AM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 Next >

Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma

May 27, 2025

From Apollo Technology Capital Corporation

Via GlobeNewswire

MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement

May 26, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.

May 23, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting

May 23, 2025

From Apollo Technology Capital Corporation

Via GlobeNewswire

MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June

May 22, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings

May 21, 2025

From MediPharm Labs Corp.

Via GlobeNewswire

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth ↗

November 14, 2024

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024...

Via Benzinga

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY ↗

August 14, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...

Via Benzinga

Topics Cannabis

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now ↗

August 09, 2024

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,...

Via Benzinga

Topics Cannabis

Executive Changes In Cannabis Industry You Should Know About, New Appointments & More ↗

July 03, 2024

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as...

Via Benzinga

Topics Cannabis

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method ↗

June 20, 2024

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to...

Via Benzinga

Topics Cannabis

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position' ↗

May 15, 2024

Via Benzinga

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses ↗

March 27, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,...

Via Benzinga

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil ↗

February 07, 2024

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products...

Via Benzinga

Topics Cannabis

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 ↗

December 22, 2023

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and...

Via Benzinga

Topics Cannabis

MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report ↗

November 14, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of...

Via Benzinga

MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M ↗

October 02, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis

Via Benzinga

MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next ↗

September 20, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C.

Via Benzinga

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

December 22, 2022

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets...

Via Newsfile

Topics Cannabis

MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO ↗

November 15, 2021

CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS...

Via Benzinga

Topics Cannabis

MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director ↗

October 21, 2021

MediPharm Labs Corp. (TSX:LABS) (OTCQX:

Via Benzinga

MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia ↗

August 31, 2021

MediPharm Labs Corp. (TSX:LABS) (OTCQX:

Via Benzinga

MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY ↗

August 16, 2021

MediPharm Labs Corp. (TSX:LABS) (OTCQX:

Via Benzinga

MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License ↗

July 14, 2021

Pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQX...

Via Benzinga

Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come

July 09, 2021

Via FinancialNewsMedia

Topics Cannabis

MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma ↗

June 08, 2021

MediPharm Labs Corp. (TSX:LABS) (OTCQX:

Via Benzinga

Topics Cannabis

MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know ↗

May 17, 2021

MediPharm Labs Corp. (TSX:LABS) (OTCQX:

Via Benzinga

Topics Cannabis

Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick Pace

April 29, 2021

Via FinancialNewsMedia

Topics Cannabis Intellectual Property Law Enforcement

Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

April 13, 2021

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the...

From IM Cannabis Corp.

Via AccessWire

Topics Cannabis Law Enforcement

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.